Liu S - Search Results

1

Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma.

Li Q, Ma L, Qiu B, Wen Y, Liang W, Hu W, Chen N, Zhang T, Xu S, Chen L, Guo M, Zhao Y, Liu S, Guo J, Wang J, Wang S, Wang X, Pang Q, Long H, Liu H. Li Q, et al. Among authors: liu h, liu s. Curr Oncol. 2021 Apr 7;28(2):1424-1436. doi: 10.3390/curroncol28020135. Curr Oncol. 2021. PMID: 33916930 Free PMC article.

2

Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical study.

Liu S, Qiu B, Chen L, Wang F, Liang Y, Cai P, Zhang L, Chen Z, Liu S, Liu M, Liu H. Liu S, et al. Among authors: liu h, liu m. Radiat Oncol. 2015 May 27;10:118. doi: 10.1186/s13014-015-0421-9. Radiat Oncol. 2015. PMID: 26014133 Free PMC article.

3

Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer.

Liu SR, Qiu B, Yang H, Liang Y, Wang F, Liu SL, Chen ZL, Zhang L, Liu MZ, Wang SY, Lin LF, Liu H. Liu SR, et al. Ann Surg Oncol. 2016 Jun;23(6):2115-22. doi: 10.1245/s10434-015-5076-0. Epub 2016 Feb 17. Ann Surg Oncol. 2016. PMID: 26887852

4

Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.

Ma L, Luo GY, Ren YF, Qiu B, Yang H, Xie CX, Liu SR, Liu SL, Chen ZL, Li Q, Fu JH, Liu MZ, Hu YH, Ye WF, Liu H. Ma L, et al. Chin J Cancer. 2017 Jan 11;36(1):8. doi: 10.1186/s40880-016-0171-6. Chin J Cancer. 2017. PMID: 28077159 Free PMC article.

5

Differential expression profiles of long noncoding RNAs in synchronous multiple and solitary primary esophageal squamous cell carcinomas: A microarray analysis.

Li QW, Ma L, Qiu B, Yang H, Zhu YJ, Qiang MY, Liu SR, Chen NB, Guo JY, Cai LZ, Wang JY, Zhang X, Liu H. Li QW, et al. J Cell Biochem. 2019 Feb;120(2):2439-2453. doi: 10.1002/jcb.27536. Epub 2018 Oct 15. J Cell Biochem. 2019. PMID: 30324748

6

Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study.

Li QW, Qiu B, Liang WH, Wang JY, Hu WM, Zhang T, Xu SB, López J, Chen NB, Guo MZ, Zhao Y, Chen LJ, Liu SR, Yun JP, Guo JY, Wang SY, Wang X, Zhang L, Yue DS, Liao ZX, Lin SH, Long H, Pang QS, Liu H. Li QW, et al. J Cancer. 2020 Aug 25;11(20):6114-6121. doi: 10.7150/jca.47119. eCollection 2020. J Cancer. 2020. PMID: 32922551 Free PMC article.

7

Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.

Zheng SH, Liu SR, Wang HB, Wei YH, Li H, Wang GN, Huang ZL, Ding SR, Chen C, Tao YL, Li XH, Glorieux C, Huang P, Wu YF, Xia YF. Zheng SH, et al. JAMA Netw Open. 2021 Dec 1;4(12):e2138444. doi: 10.1001/jamanetworkopen.2021.38444. JAMA Netw Open. 2021. PMID: 34902036 Free PMC article.

8

EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma.

Ding S, Wang X, Lv D, Tao Y, Liu S, Chen C, Huang Z, Zheng S, Wei Y, Kang T, Xia Y. Ding S, et al. Among authors: liu s. Cancer Lett. 2022 Feb 28;527:49-65. doi: 10.1016/j.canlet.2021.12.010. Epub 2021 Dec 11. Cancer Lett. 2022. PMID: 34906623 Free article.

9

Hypofractionated Radiation Therapy Combined With Weekly Chemotherapy in Patients With Unresectable or Recurrent Thymic Epithelial Tumor: A Prospective, Single-Arm Phase 2 Study (GASTO-1042).

Chu C, Liang Y, Lin X, Liu Y, Liu S, Guo J, Wang D, Wang J, Liu H, Qiu B. Chu C, et al. Among authors: liu y, liu h, liu s. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):89-98. doi: 10.1016/j.ijrobp.2022.05.015. Epub 2022 May 20. Int J Radiat Oncol Biol Phys. 2022. PMID: 35598797 Clinical Trial.

10

Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [¹⁸F]FDG PET/CT imaging: quantitative analysis of [¹⁸F]FDG uptake in primary tumors and metastatic lymph nodes.

Wang D, Zhang X, Liu H, Qiu B, Liu S, Zheng C, Fu J, Mo Y, Chen N, Zhou R, Chu C, Liu F, Guo J, Zhou Y, Zhou Y, Fan W, Liu H. Wang D, et al. Among authors: liu h, liu s, liu f. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4692-4704. doi: 10.1007/s00259-022-05904-8. Epub 2022 Jul 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 35819498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71,705 results

Search Page